Technical Tuesday: Viral Gene Therapy – How Can the Industry Drive Down the Cost of Goods to Better Serve the Patients?
19 Jul 2022
5.30-6.30pm SGT | Online
The session will cover the following:
- The cost of dose challenge for Gene Therapy products
- Leveraging cost modelling tools to understand process cost drivers and impact of process optimization – case study
- How can process optimization help to reduce cost of dose
- How Process intensification can be used to optimize cost
Led by:
Emmanuelle Cameau, Strategic Technology Partnership Leader - Cell and Gene Therapy EMEA at Pall Corporation
Emmanuelle has more than 14 years’ experience Biotechnology Process Development and GMP production. Highly skilled in the field of cell culture applications, Emmanuelle joined Pall Biotech almost 10 years ago first as a Bioprocess Specialist (BPS) during 4 years. She then transitioned to the Bioreactor Applications team, where she was Principal Bioreactor Specialist until March 2021 when she joined the newly formed Gene Therapy business Unit as Strategic Technology Partnership Leader. Prior to Pall, Emmanuelle worked as Biotech Process Sciences Upstream Process development engineer at Merck Serono for 4 years. She received her Biotechnology Engineer diploma from the former Ecole Supérieure d’Ingénieurs de Luminy (now Polytech Marseille). Emmanuelle is a keen horse rider and enjoys competing in horse jumping competitions.